PDF Cover

Percutaneous Heart Pump Devices Market

Percutaneous Heart Pump Devices Market

The market for Percutaneous Heart Pump Devices was estimated at $1.1 billion in 2024; it is anticipated to increase to $1.8 billion by 2030, with projections indicating growth to around $2.8 billion by 2035.

Report ID:DS1801277
Author:Debadatta Patel - Senior Consultant
Published Date:June 2025
Datatree
Life Science
Medical Device
Percutaneous Heart Pump Devices
Share
Report Summary
Table of Contents
Methodology
Market Data

Global Percutaneous Heart Pump Devices Market Outlook

Revenue, 2024

$1.1B

Forecast, 2034

$2.6B

CAGR, 2025 - 2034

9.5%

The Percutaneous Heart Pump Devices industry revenue is expected to be around $1.1 billion in 2025 and expected to showcase growth with 9.5% CAGR between 2025 and 2034. The remarkable growth pattern indicates that Percutaneous Heart Pump Devices are crucial in the medical equipment sector due to advancements in heart care and the rise in elderly population globally leading to an increased occurrence of heart ailments along with improvements in minimally invasive heart procedures driving market growth substantially research and technological progress play a key role sustaining the need for these devices, in modern healthcare setups. Emphasizing safety and comfort has become a key priority with Percutaneous Heart Pump Devices showcasing the value of advanced medical technology in enhancing health results and instilling trust in patients well being. Given these considerations it is apparent that these devices will play a role, in shaping the future of healthcare practices.

Perforated Heart Pump Devices are tools created to enhance blood flow in people with heart failure by lessening the strain put upon the heart muscle. They are known for being invasive and user friendly devices that perform well and can be used in various important heart related procedures due, to their biocompatible design.

Percutaneous Heart Pump Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034

Market Key Insights

  • The Percutaneous Heart Pump Devices market is projected to grow from $1.1 billion in 2024 to $2.6 billion in 2034. This represents a CAGR of 9.5%, reflecting rising demand across Treatment of Cardiovascular Diseases, Pre & Post-Operative Support and Interventional Cardiology.

  • Abbott Laboratories, Medtronic Inc., and Teleflex Incorporated are among the leading players in this market, shaping its competitive landscape.

  • U.S. and Germany are the top markets within the Percutaneous Heart Pump Devices market and are expected to observe the growth CAGR of 6.9% to 10.0% between 2024 and 2030.
  • Emerging markets including India, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 9.1% to 11.9%.

  • Transition like Technological Advancements is expected to add $196 million to the Percutaneous Heart Pump Devices market growth by 2030

  • The Percutaneous Heart Pump Devices market is set to add $1.6 billion between 2024 and 2034, with manufacturer targeting Acute Myocardial Infarction & Cardiogenic Shock Application projected to gain a larger market share.
  • With

    increasing prevalence of cardiovascular diseases, and

    technological advancements in percutaneous heart pump devices, Percutaneous Heart Pump Devices market to expand 148% between 2024 and 2034.

percutaneous heart pump devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the Percutaneous Heart Pump Devices

The ongoing progress in medical device technology offers prospects for Percutaneous Heart Pump Devices . Innovations in downsizing and the incorporation of predictive analytics powered by AI are also expected to greatly improve device performance levels significantly. The creation of these cutting edge devices has the potential to significantly boost market expansion by generating demand, in both the near and long term.

Growth Opportunities in North America and Asia Pacific

North America Outlook

A concentrated analysis of the Percutaneous Heart Pump Devices market in North America unveils a wealth of opportunities. The region, already established as a hub for healthcare innovation, has a well-structured and advanced healthcare infrastructure, which adds to the market attractiveness. Competition is high here, with key players such as Boston Scientific Corporation and Medtronic making significant inroads. The pervasiveness of chronic heart diseases and high levels of medical insurance coverage are key market drivers. The continual adoption of cutting-edge technologies, many of them introduced by local manufacturers, is also stimulating market expansion.

Asia Pacific Outlook

Asia-Pacifics Percutaneous Heart Pump Devices market is an emerging powerhouse. It is poised to demonstrate significant growth due to factors such as an aging population with an increasingly high prevalence of heart diseases. Competition is heating up with a swell of both global and domestic manufacturers vying for market share. Key opportunities here lie in responding to the enormous unmet medical needs and in advancing technologies, such as the application of AI in healthcare, to further increase the efficiency and effectiveness of Percutaneous Heart Pump Devices. Rapid urbanization and increased healthcare spending are powerful drivers behind this trend.

Market Dynamics and Supply Chain

01

Driver: Increasing prevalence of cardiovascular diseases, and Increasing healthcare expenditures and favorable insurance policies

The increasing prevalence of heart related illnesses on a scale is also leading to an increased need for Percutaneous Heart Pump Devices. Thanks to the aging population and health problems related to lifestyle choices causing conditions such, as heart failure and coronary artery disease to rise in numbers the use of these devices has also become necessary because of their less invasive approach and high rate of effectiveness.

The overall increase in global healthcare spending, combined with advantageous insurance policies, particularly in developed nations, is also facilitating greater access and affordability to Percutaneous Heart Pump Devices. This financial accessibility engenders a positive growth trajectory for these devices markets, contributing to their boosted industry relevance and application.


Significant progress in the medical technology sector is also driving the adoption of Percutaneous Heart Pump Devices as an option for cardiac care advancements continue to improve device performance in terms of size reduction and effectiveness while enhancing durability factors making these devices more dependable and user friendly thus expanding their utilization, in intricate cardiac interventions.

02

Restraint: High Cost and Limited Reimbursement

The high costs linked to acquiring and upkeeping Percutaneous Heart Pump Devices might hinder market expansion efforts. These devices incorporate technology and come with substantial manufacturing expenses that reflect in their expensive nature alongside limited insurance coverage options that could create a financial obstacle for various patients. In regions, with developing economies where patients frequently cover costs themselves it could place a financial strain on them potentially limiting the growth and widespread adoption of these devices.

03

Opportunity: Strategic Collaborations and Partnerships and Expansion into Underserved Markets

Forming partnerships with both local and international entities has the potential to significantly boost the market reach of Percutaneous Heart Pump Devices. Collaborations play a role in leveraging collective resources, technical knowledge and varied product offerings. Engaging in agreements, for sharing technology embarking on research and development projects or implementing co marketing approaches can result in various advantages ultimately leading to improved market visibility and greater revenue opportunities.


Percutaneous heart pump devices are becoming increasingly popular in established areas such as North America and Europe; however some significant opportunities exist in emerging markets like China, India and Brazil due to the growth of healthcare spending rising instances of cardiovascular disease and ongoing improvements in healthcare policies. The unexplored potential in these regions presents an outlook, for the market expansion of percutaneous heart pump devices.

04

Challenge: Lack of Training and Complexities in Operation

Percutaneous Heart Pump Devices are high-end technologically-driven medical equipment that requires skilled healthcare professionals for the correct implantation and operation. A shortage of such trained personnel or any lapse in the appropriate handling or understanding of such complex devices could lead to severe health consequences for the patient.

Supply Chain Landscape

1
Raw Material Procurement

International Specialty Products Inc

Bayer AG

2
Device Production

Medtronic Plc

Abbott Laboratories

3
Marketing & Sales

Boston Scientific Corporation

Teleflex Incorporated

4
End User

Cardiology Centers

Hospitals

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of Percutaneous Heart Pump Devices in Treatment of Cardiovascular Diseases, Pre & Post-Operative Support & Interventional Cardiology

Treatment of Cardiovascular Diseases

Percutaneous heart pump devices play a pivotal role in the field of cardiology, assisting in the treatment of various cardiovascular diseases like heart failure and myocardial infarction. These sophisticated devices, including Impella CP and TandemHeart, provide enhanced blood circulation, ensuring optimal cardiac output. Prominent players in this domain include Abbott Laboratories and Teleflex Incorporated, known for their innovative technologies and superior product range.

Pre & Post-Operative Support

A different aspect of their utility is seen in pre-operative and post-operative cardiac support. Devices like the Percutaneous Ventricular Assist Device are used to stabilize patients before surgeries and offer reliable support post operations, reducing recovery time. Medtronic and Getinge Group, leaders in this arena, offer high-quality solutions that have strengthened their market position.

Interventional Cardiology

In interventional cardiology, percutaneous heart pump devices are used during critical procedures like angioplasty and stenting. The ability of devices like the Intra-Aortic Balloon Pump to rapidly restore blood flow significantly improves patient outcomes. Companies like Boston Scientific and LivaNova have set a benchmark in this field with their cutting-edge products and robust market presence.

Recent Developments

December 2024

Medtronic, a renowned name in the medical industry, launched a next-generation percutaneous heart pump device, increasing its market share impressively and demonstrating commitment to life-changing technologies

October 2024

Boston Scientific, a leading provider, secured FDA approval for their novel non-surgical percutaneous heart pump device drawing attention to its less invasive approach

July 2024

Abbott Labs launched a clinical trial for their upgraded percutaneous heart pump device, highlighting theindustry'sshift toward evidence-based technological upgrades.

The medical devices industry has been making significant strides in product innovation, with Percutaneous Heart Pump Devices at the forefront. This industry has been experiencing dynamic shifts characterized by new technologies, advanced applications, and evolving market trends. Percutaneous Heart Pumps, external cardiac support solutions, are instrumental in treating heart complications.

Impact of Industry Transitions on the Percutaneous Heart Pump Devices Market

As a core segment of the Medical Device industry, the Percutaneous Heart Pump Devices market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements and Regulatory Shifts have redefined priorities across the Medical Device sector, influencing how the Percutaneous Heart Pump Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Technological Advancements

The percutaneous heart pump devices industry has witnessed significant technological advancements in recent years. Devices have evolved in terms of design, materials, and functionality, increasing the efficiency, efficacy, and reliability of the treatment. Advancements such as miniaturization of devices and enhancement in cardiac support offered by the devices are notable gamechangers in the market. For instance, newer models are equipped with superior features and imaging capabilities, providing accurate results, reduced complications, and improved patient outcomes. The impact of this transition is felt in associated industries like healthcare technology and medical device manufacturing, bolstering their growth and innovation. This industry transition is expected to add $196 million in the industry revenue between 2024 and 2030.
02

Regulatory Shifts

Percutaneous heart pump devices have also been influenced by regulatory shifts globally. There has been an increased focus on strict standards to ensure device safety and performance, given the critical nature of these devices in cardiac interventions. Regulatory bodies like FDA and EU have introduced stringent regulation guidelines and approval processes, ensuring enhanced scrutiny in device approval and clinical trials, resulting in safer and more reliable devices in the marketplace.

Report Price: $4,200

Related Reports

Loading related reports...